Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from EUDA Health Holdings ( (EUDA) ).
On December 4, 2025, EUDA Health Holdings Limited issued and sold to an accredited investor a warrant immediately exercisable into 2,000,000 newly issued ordinary shares for an aggregate purchase price of $100,000, under an existing shelf registration and prospectus. On December 16, 2025, the company amended the warrant terms, cutting the exercise price from $6.00 to $4.00 per share and lowering the Nasdaq share-price threshold that can trigger a forced exercise from $7.50 to $6.00, a move that could make conversion more attractive to the investor and potentially accelerate EUDA’s ability to raise equity capital.
The most recent analyst rating on (EUDA) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on EUDA Health Holdings stock, see the EUDA Stock Forecast page.
More about EUDA Health Holdings
EUDA Health Holdings Limited is a Singapore-based healthcare company whose shares are listed on Nasdaq. The firm operates within the health sector, using public capital markets to support its business activities and growth initiatives.
Average Trading Volume: 80,816
Technical Sentiment Signal: Sell
Current Market Cap: $99.06M
For a thorough assessment of EUDA stock, go to TipRanks’ Stock Analysis page.